eNeura Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:eNeura Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012889
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
eNeura Inc (eNeura) formerly eNeura Therapeutics LLC, is a medical device company that offers portable, non-invasive transcranial magnetic stimulation devices for treating migraine. The company offers products such as flagship product and eNeura Spring TMS device. Its SpringTMS device is placed at the back of the head for less than a minute, generating single magnetic pulse that induces a mild electric current in the back of the brain. eNeura generates a single magnetic pulse that induces a mild electric current in the back of the brain. The company offers its products in the UK. eNeura is headquartered in Baltimore, Maryland, the US.

eNeura Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
eNeura Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
eNeura Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
eNeura Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
eNeura Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
eNeura Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
eNeura Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Eneura Raises Additional USD1.1 Million in Venture Financing 10
eNeura Raises Additional USD0.5 Million Financing 11
eNeura Raises Additional USD0.05 Million Financing 12
eNeura Therapeutics Raises USD5.8 Million in Venture Financing 13
eNeura Therapeutics Raises US$1.7 In Venture Financing 14
eNeura Therapeutics Raises US$2 Million In Venture Financing 15
eNeura Therapeutics Raises US$0.6 Million In Venture Financing 16
eNeura Therapeutics Raises US$3.2 Million In Venture Financing 17
Neuralieve Raises US$0.1 Million In Venture Financing 18
NeuraLieve Raises US$1 Million In Venture Financing 19
Acquisition 20
Orthofix International Enters into Option Agreement to Acquire eNeura 20
eNeura Inc – Key Competitors 21
eNeura Inc – Key Employees 22
eNeura Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
eNeura Inc, Medical Equipment, Key Facts 2
eNeura Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
eNeura Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
eNeura Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
eNeura Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
eNeura Inc, Deals By Market, 2011 to YTD 2017 8
eNeura Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Eneura Raises Additional USD1.1 Million in Venture Financing 10
eNeura Raises Additional USD0.5 Million Financing 11
eNeura Raises Additional USD0.05 Million Financing 12
eNeura Therapeutics Raises USD5.8 Million in Venture Financing 13
eNeura Therapeutics Raises US$1.7 In Venture Financing 14
eNeura Therapeutics Raises US$2 Million In Venture Financing 15
eNeura Therapeutics Raises US$0.6 Million In Venture Financing 16
eNeura Therapeutics Raises US$3.2 Million In Venture Financing 17
Neuralieve Raises US$0.1 Million In Venture Financing 18
NeuraLieve Raises US$1 Million In Venture Financing 19
Orthofix International Enters into Option Agreement to Acquire eNeura 20
eNeura Inc, Key Competitors 21
eNeura Inc, Key Employees 22
eNeura Inc, Other Locations 23
eNeura Inc, Subsidiaries 23

★海外企業調査レポート[eNeura Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CIMB Private Banking:企業の戦略・SWOT・財務分析
    CIMB Private Banking - Strategy, SWOT and Corporate Finance Report Summary CIMB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alliant Energy Corporation:企業の戦略・SWOT・財務情報
    Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CellProthera-製薬・医療分野:企業M&A・提携分析
    Summary CellProthera (CellProthera) focuses on the development of therapeutic solutions for the regeneration of organs which are damaged by disease or trauma from autologous blood peripheral stem cells. The company’s lead candidate ProtheraCytes, is an advanced therapy medicinal product within tissu …
  • Arsenal Holdings PLC:企業の戦略的SWOT分析
    Arsenal Holdings PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • National Grid Plc:企業の発電所・SWOT分析2018
    National Grid Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Patrys Ltd (PAB):企業の財務・戦略的SWOT分析
    Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology. The company's pipeline products include PAT-SC an immunoglobulin M type antibody used for the treatment of gastric cancer PAT-SM is a fully human m …
  • Gilbane Inc:企業の戦略・SWOT・財務分析
    Gilbane Inc - Strategy, SWOT and Corporate Finance Report Summary Gilbane Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Concho Resources Inc.:企業の戦略・SWOT・財務分析
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • OmniComm Systems Inc (OMCM):医療機器:M&Aディール及び事業提携情報
    Summary OmniComm Systems Inc (OmniComm) is a provider of electronic data capture and eClinical software and services. It provides web-based applications to pharmaceutical, biotech and medical device companies. The company’s solutions allow clinical trial sponsors and investigative sites to securely …
  • CHC Group LLC:企業の戦略的SWOT分析
    CHC Group LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • JAMCO Corporation:企業の戦略・SWOT・財務情報
    JAMCO Corporation - Strategy, SWOT and Corporate Finance Report Summary JAMCO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Asseco Poland SA (ACP):企業の財務・戦略的SWOT分析
    Summary Asseco Poland SA (Asseco) is a technology company that offers information processing solutions. The company provides products such as proprietary software and services, third party software and services; and hardware and infrastructure. Asseco also offers services that include cloud services …
  • Aviation Industry Corporation of China:企業の戦略・SWOT・財務情報
    Aviation Industry Corporation of China - Strategy, SWOT and Corporate Finance Report Summary Aviation Industry Corporation of China - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Universal Music Group Inc:企業の戦略的SWOT分析
    Universal Music Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • SNGN Romgaz SA (SNG):企業の財務・戦略的SWOT分析
    Summary SNGN Romgaz SA (Romgaz) is an oil and gas company which explores produces and supplies natural gas. The company's activities include exploration of petroleum onshore and offshore, natural gas production, electric power production, trading and technological transport. Romgaz through its well …
  • Lycatel Services Limited:企業の戦略的SWOT分析
    Lycatel Services Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • LifeAssay Diagnostics (Pty) Ltd:企業の製品パイプライン分析2018
    Summary LifeAssay Diagnostics (Pty) Ltd (LifeAssay) is a medical device manufacturer. The company offers urine analysis, urine adulteration tests, lifestyle tests, lateral flow tests and industrial tests. It manufactures non-invasive semi-quantitative dipstick tests intended to measure selective phy …
  • Georgia Power Co:企業の発電所・SWOT分析2018
    Georgia Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Forendo Pharma Ltd (Forendo Pharma) is a drug development company that concentrates on tissue specific regulation of sex hormone effects. The company’s product pipeline include fispemifene, which is in clinical phase II development and intended for the treatment of lower urinary tract sympto …
  • C.A. Curtze Co. Inc.:企業の戦略・SWOT・財務分析
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆